4.6 Article

Soluble epoxide hydrolase inhibition modulates vascular remodeling

出版社

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpheart.00543.2009

关键词

endothelium; hypertrophy; hyperplasia; epoxyeicosatrienoic acids; hypertension; mice

资金

  1. National Institutes of Health (NIH) [HL-59699, F31 HL-087723, R37 E5-02710]
  2. Advancing a Healthier Wisconsin

向作者/读者索取更多资源

Simpkins AN, Rudic RD, Roy S, Tsai HJ, Hammock BD, Imig JD. Soluble epoxide hydrolase inhibition modulates vascular remodeling. Am J Physiol Heart Circ Physiol 298: H795-H806, 2010. First published December 24, 2009; doi:10.1152/ajpheart.00543.2009.-The soluble epoxide hydrolase enzyme (SEH) and vascular remodeling are associated with cardiovascular disease. Although inhibition of SEH prevents smooth muscle cell proliferation in vitro, the effects of SEH inhibition on vascular remodeling in vivo and mechanisms of these effects remain unclear. Herein we determined the effects of SEH antagonism in an endothelium intact model of vascular remodeling induced by flow reduction and an endothelium denuded model of vascular injury. We demonstrated that chronic treatment of spontaneously hypertensive stroke-prone rats with 12-(3-adamantan-1-yl-ureido) dodecanoic acid, an inhibitor of SEH, improved the increment of inward remodeling induced by common carotid ligation to a level that was comparable with normotensive Wistar Kyoto rats. Similarly, mice with deletion of the gene responsible for the production of the SEH enzyme (Ephx2(-/-)) demonstrated enhanced inward vascular remodeling induced by carotid ligation. However, the hyperplastic response induced by vascular injury that denudes the endothelium was unabated by SEH inhibition or Ephx2 gene deletion. These results suggest that SEH inhibition or Ephx2 gene deletion antagonizes neointimal formation in vivo by mechanisms that are endothelium dependent. Thus SEH inhibition may have therapeutic potential for flow-induced remodeling and neointimal formation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Rehabilitation

Benefits of an interdisciplinary stroke clinic: addressing a gap in physical therapy at post-stroke neurology follow-up

Nandakumar Nagaraja, Alison R. Kraus, Dorian K. Rose, Esther B. Olasoji, Anna Y. Khanna, Alexis N. Simpkins, Christina A. Wilson, Rondalyn R. Dickens, Vishnumurthy Shushrutha Hedna, Carolyn Geis, Teddy Youn, Michelle M. Musalo

Summary: The interdisciplinary stroke clinic identified a significant number of post-acute stroke survivors appropriate for additional rehabilitation. The evaluation scales that most closely correlated with referral for additional therapy were the 10-Meter Walk Test (10MWT) and Short Form-Stroke Impact Scale (SF-SIS).

DISABILITY AND REHABILITATION (2022)

Editorial Material Clinical Neurology

Risk of Acute Ischemic Stroke in Patients 65 and Older Is Early After COVID-19 Diagnosis

Alexis N. Simpkins, Alain Lekoubou

Summary: COVID-19 can lead to acute ischemic stroke (AIS) as a complication beyond respiratory illness. Factors like hypercoagulability, inflammation, cardiac dysfunction, and endothelial inflammation during the infectious phase may cause thrombotic events and cerebral ischemia. Studies on the risk of stroke in COVID-19 have shown substantial variation, with most focusing on AIS incidence in hospitalized patients. The large-scale screening of COVID-19 in both symptomatic and asymptomatic individuals upon hospital admission has made it challenging to determine the true association between COVID-19 and an increased risk of AIS.

NEUROLOGY (2022)

Article Clinical Neurology

Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study

Shadi Yaghi, Liqi Shu, Ekaterina Bakradze, Setareh Salehi Omran, James A. Giles, Jordan Y. Amar, Nils Henninger, Marwa Elnazeir, Ava L. Liberman, Khadean Moncrieffe, Jenny Lu, Richa Sharma, Yee Cheng, Adeel S. Zubair, Alexis N. Simpkins, Grace T. Li, Justin Chi Kung, Dezaray Perez, Mirjam Heldner, Adrian Scutelnic, David Seiffge, Bernhard Siepen, Aaron Rothstein, Ossama Khazaal, David Do, Sami Al Kasab, Line Abdul Rahman, Eva A. Mistry, Deborah Kerrigan, Hayden Lafever, Thanh N. Nguyen, Piers Klein, Hugo Aparicio, Jennifer Frontera, Lindsey Kuohn, Shashank Agarwal, Christoph Stretz, Narendra Kala, Sleiman El Jamal, Alison Chang, Shawna Cutting, Han Xiao, Adam de Havenon, Varsha Muddasani, Teddy Wu, Duncan Wilson, Amre Nouh, Syed Daniyal Asad, Abid Qureshi, Justin Moore, Pooja Khatri, Yasmin Aziz, Bryce Casteigne, Muhib Khan, Yao Cheng, Brian Mac Grory, Martin Weiss, Dylan Ryan, Maria Cristina Vedovati, Maurizio Paciaroni, James E. Siegler, Scott Kamen, Siyuan Yu, Christopher R. Leon Guerrero, Eugenie Atallah, Gian Marco De Marchis, Alex Brehm, Tolga Dittrich, Marios Psychogios, Ronald Alvarado-Dyer, Tareq Kass-Hout, Shyam Prabhakaran, Tristan Honda, David S. Liebeskind, Karen Furie

Summary: The study compared the effectiveness of DOACs and warfarin in treating CVT, showing similar outcomes in recurrent venous thrombosis, death, and partial/complete recanalization rates between the two groups, but lower risk of major hemorrhage in the DOACs treatment group.

STROKE (2022)

Article Peripheral Vascular Disease

Apparent Treatment-Resistant Hypertension Among Stroke Survivors: A Transcontinental Study Assessing Impact of Race and Geography

Fred Stephen Sarfo, Esther Olasoji, Grant P. Banfill, Bruce Ovbiagele, Alexis N. Simpkins

Summary: The prevalence and predictors of hypertension in stroke survivors vary by race and geography. However, the impact of race and geography on treatment-resistant hypertension needs further investigation.

AMERICAN JOURNAL OF HYPERTENSION (2022)

Editorial Material Medicine, Research & Experimental

SARS-CoV-2 spike protein causes cardiovascular disease independent of viral infection

John D. Imig

Summary: The SARS-CoV-2 virus's S protein has been found to potentially cause damage to multiple organs through binding to receptors, particularly affecting human cardiac pericytes. Further investigations are needed to evaluate the S protein's impact on pericytes in various organs and explore the efficacy of CD147 receptor-blocking therapies in reducing organ damage.

CLINICAL SCIENCE (2022)

Editorial Material Public, Environmental & Occupational Health

THE IMPORTANCE OF INCORPORATING STROKE SURVIVORS' HEALTH PERCEPTIONS IN ADDRESSING HEALTH CARE DISPARITIES

Rondalyn R. Dickens, Tirisham Gyang, Sadie Sanders, Charles Ellis, Alexis N. Simpkins

Summary: Patient-centered research on health care disparities among stroke patients is limited. Existing studies mainly focus on patients' perceptions using validated questionnaires. However, there are several domains that need further investigation, including medication side effects, acceptance of stroke diagnosis, consequences of symptoms, importance of medications for long-term health, and perception of ease of access to equitable health care. The representation of diverse groups in stroke surveys is low. Limited studies have explored health disparities and beliefs of under-represented stroke survivors. Future research should focus on using patient perception questionnaires with underrepresented populations. Improvements in this field can promote patient-centered care and bridge gaps in health care equity.

ETHNICITY & DISEASE (2022)

Article Clinical Neurology

Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality

Thanh N. Nguyen, Muhammad M. Qureshi, Piers Klein, Hiroshi Yamagami, Mohamad Abdalkader, Robert Mikulik, Anvitha Sathya, Ossama Yassin Mansour, Anna Czlonkowska, Hannah Lo, Thalia S. Field, Andreas Charidimou, Soma Banerjee, Shadi Yaghi, James E. Siegler, Petra Sedova, Joseph Kwan, Diana Aguiar de Sousa, Jelle Demeestere, Violiza Inoa, Setareh Salehi Omran, Liqun Zhang, Patrik Michel, Davide Strambo, Joao Pedro Marto, Raul G. Nogueira

Summary: This study evaluated the impact of the COVID-19 pandemic on CVT hospitalization volume and in-hospital mortality, finding no changes during the first year of the pandemic. However, there was an increase in CVT hospitalization volume and related mortality in the first 5 months of 2021, partially attributable to vaccine-induced immune thrombotic thrombocytopenia.

JOURNAL OF STROKE (2022)

Article Neurosciences

Manganese-enhanced magnetic resonance imaging method detects age-related impairments in axonal transport in mice and attenuation of the impairments by a microtubule-stabilizing compound

Alvin V. Terry Jr, Wayne D. Beck, Ping-Chang Lin, Patrick M. Callahan, R. Daniel Rudic, Mark W. Hamrick

Summary: In this study, a new method using manganese-enhanced magnetic resonance imaging (MEMRI) was developed to measure axonal transport rates in real time in mice. The study evaluated the effects of age and a microtubule-stabilizing agent called Epothilone D on axonal transport rates. The results showed that aging led to decreased axonal transport rates, and treatment with Epothilone D increased axonal transport rates in aged mice. This study provides further evidence for the potential of microtubule-based therapeutic strategies in age-related neurological disorders.

BRAIN RESEARCH (2022)

Article Clinical Neurology

Estimating Perfusion Deficits in Acute Stroke Patients Without Perfusion Imaging

Dennys Reyes, Alexis N. Simpkins, Emi Hitomi, John K. Lynch, Amie W. Hsia, Zurab Nadareishvili, Marie Luby, Lawrence L. Latour, Richard Leigh

Summary: In this study, the National Institutes of Health (NIH) FHV score was developed to quantify the burden of fluid-attenuated inversion recovery hyperintense vessels (FHVs) and investigate its potential as a surrogate for perfusion weighted imaging (PWI). The study found a strong association between the NIH-FHV score and PWI lesion volume, and when combined with diffusion weighted imaging, it may be helpful in determining the presence of a clinically relevant diffusion-perfusion mismatch in situations where perfusion imaging is not available.

STROKE (2022)

Article Clinical Neurology

Trends in outpatient rehabilitation use for stroke survivors

Esther B. Olasoji, Daniel K. Uhm, Oluwole O. Awosika, Sylvain Dor, Carolyn Geis, Alexis N. Simpkins

Summary: In the rehabilitation of stroke patients, there has been a shift towards outpatient rehabilitation services, emphasizing its importance as an expanding healthcare resource for reducing stroke-related disabilities.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2022)

Article Clinical Neurology

Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis Analysis of the ACTION-CVT Study

Liqi Shu, Ekaterina Bakradze, Setareh Salehi Omran, James Giles, Jordan Amar, Nils Henninger, Marwa Elnazeir, Ava Liberman, Khadean Moncrieffe, Jenny Rotblat, Richa Sharma, Yee Cheng, Adeel S. Zubair, Alexis Simpkins, Grace Li, Justin Kung, Dezaray Perez, Mirjam R. Heldner, Adrian Scutelnic, Rascha Von Martial, Bernhard Siepen, Aaron Rothstein, Ossama Khazaal, David Do, Sami Al Kasab, Line Abdul Rahman, Eva A. Mistry, Deborah Kerrigan, Hayden Lafever, Thanh N. Nguyen, Piers Klein, Hugo J. Aparicio, Jennifer A. Frontera, Lindsey Kuohn, Shashank Agarwal, Christoph Stretz, Narendra Kala, Sleiman ElJamal, Allison Chang, Shawna Cutting, Fransisca Indraswari, Adam de Havenon, Varsha Muddasani, Teddy Wu, Duncan Wilson, Amre Nouh, Daniyal Asad, Abid Qureshi, Justin Moore, Pooja Khatri, Yasmin Aziz, Bryce Casteigne, Muhib Khan, Yao Cheng, Brian MacGrory, Martin Weiss, Dylan Ryan, Maria Cristina Vedovati, Maurizio Paciaroni, James Siegler, Scott Kamen, Siyuan Yu, Christopher Leon Guerrero, Eugenie Atallah, Gian Marco De Marchis, Alex Brehm, Tolga Dittrich, Marios Psychogios, Ronald Alvarado-Dyer, Tareq Kass-Hout, Shyam Prabhakaran, Tristan Honda, David Liebeskind, Karen Furie, Shadi Yaghi

Summary: This study aimed to identify predictors of recurrent venous thrombosis in patients with CVT. The study found that Black race, history of VTE, and the presence of one or more positive antiphospholipid antibodies were associated with recurrent venous thrombosis among patients with CVT.

NEUROLOGY (2022)

Editorial Material Clinical Neurology

COVID-19 Exposures, Vaccines, and Acute Ischemic Stroke Risk On Balance and in Balance

Alexis N. Simpkins, Susan Cheng

Summary: Most stroke prevention strategies focus on optimizing various aspects of health, but the COVID-19 pandemic has highlighted the increased risk of stroke associated with the infection and vaccination. COVID-19 patients, especially those with severe respiratory manifestations, are more prone to prothrombotic and proinflammatory states, cardiac dysfunction, and stroke. Reports of thrombotic events, such as acute ischemic stroke and cerebral venous thrombosis, have also emerged post-COVID-19 vaccination. As the pandemic continues, it is essential to consider and weigh the risks of stroke from COVID-19 infection and vaccination.

NEUROLOGY (2022)

Article Pharmacology & Pharmacy

Salt-sensitive hypertension after reversal of unilateral ureteral obstruction

John D. Imig, Md Abdul Hye Khan, Anna Stavniichuk, Wojciech K. Jankiewicz, Samaneh Goorani, Michael M. Yeboah, Ashraf El-Meanawy

Summary: The incidence of ureter obstruction is increasing and recovery from this kidney injury can lead to long-term consequences such as an increased risk for salt-sensitive hypertension. A study using a RUUO model found that mice with unilateral ureteral obstruction had elevated blood pressure and decreased sodium excretion, along with renal tubular injury, inflammation, decreased vascular density, and renal fibrosis. These findings highlight the importance of addressing ureter obstruction and its potential impact on sodium excretion and hypertension.

BIOCHEMICAL PHARMACOLOGY (2023)

Review Peripheral Vascular Disease

Toward Precision Medicine: Circadian Rhythm of Blood Pressure and Chronotherapy for Hypertension-2021 NHLBI Workshop Report

Michelle L. Gumz, Daichi Shimbo, Marwah Abdalla, Ravi C. Balijepalli, Christian Benedict, Yabing Chen, David J. Earnest, Karen L. Gamble, Scott R. Garrison, Ming C. Gong, John B. Hogenesch, Yuling Hong, Jessica R. Ivy, Bina Joe, Aaron D. Laposky, Mingyu Liang, Eric J. MacLaughlin, Tami A. Martino, David M. Pollock, Susan Redline, Amy Rogers, R. Dan Rudic, Eva S. Schernhammer, George S. Stergiou, Marie-Pierre St-Onge, Xiaoling Wang, Jacqueline Wright, Young S. Oh

Summary: Healthy individuals experience variation in blood pressure over a 24-hour period, with higher levels during wakefulness and lower levels during sleep. Disruption of the blood pressure circadian rhythm has been associated with negative health outcomes such as cardiovascular disease, dementia, and chronic kidney disease. Current approaches to diagnosis and treatment do not adequately consider the circadian rhythmicity of blood pressure. This review summarizes findings from a workshop held by the National Heart, Lung, and Blood Institute to identify knowledge gaps and research opportunities related to the study of blood pressure circadian rhythm and chronotherapy for hypertension.

HYPERTENSION (2023)

暂无数据